National Institute for Health and Clinical Excellence (NICE)
Nine treatment options to be made available for adults with depression or an anxiety disorder
Six digitally enabled therapies for adults with anxiety disorders and three for adults with depression have been recommended for use in the NHS while further data is gathered, NICE has said.
The launch of NICE’s final guidance coincides with Mental Health Awareness Week. The new digital treatment options use cognitive behavioural therapy (CBT) techniques via an app or website and include the support and involvement of a NHS Talking Therapies clinician or psychological wellbeing practitioner.
Digital therapies offer an alternative way for people to access help in a way that may be more suited to their personal needs by offering flexibility around both time and location of treatment.
As the therapy is delivered via digital technology and needs less therapist time than standard care, this could free up clinical resources that could be used elsewhere in services to increase access or reduce waiting times.
Digitally enabled therapies for depression require on average 90 minutes of with a therapist. This compares with 8 hours each patient would receive with standard care.
Digitally enabled therapies for anxiety require on average 4 hours of clinician or practitioner time compared with 10 hours required for standard care.
How many more people will be able to be seen overall will depend on how many people opt for digitally enabled therapies.
One in six people report experiencing a common mental health problem such as anxiety and depression in any given week in England, according to NHS Digital.
In 2021-22, there were 527,094 referrals accessing NHS Talking Therapies for depression and anxiety services with a presenting complaint of anxiety and stress related disorders.
A formal assessment with an NHS Talking Therapies clinician or practitioner will take place prior to starting treatment to ensure the correct intervention is matched to both clinical needs and the person’s preferences.
Mark Chapman, interim director of medical technology and digital evaluation, at NICE, said:
“We know NHS Talking Therapies services are in demand and people are facing waits of several weeks. A part of the solution could be the use of digitally enabled therapies recommended by our committee which could increase the number of people receiving the treatment they need sooner.
“One of our priorities is to get the best care to people fast while at the same time ensuring value for money for the taxpayer – these digitally enabled therapies do both.
“Every person seen by an NHS Talking Therapies clinician or practitioner is assessed so their needs can be fully understood. The choice of a digitally enabled therapy must be the right one for the individual, ensuring that they get the care they need.”
Some of the digitally enabled therapies are already in use. The nine digitally enabled therapies recommended by NICE will require Digital Technology Assessment Criteria (DTAC) approval, a completed NHS Talking Therapies for anxiety and depression digitally enabled therapies assessment from NHS England, and to have a CE or UKCA mark approval before they can be used by the NHS while further evidence is generated on their clinical and cost effectiveness.
NICE will review the evidence generated before carrying out a full assessment on the clinical and cost effectiveness of these interventions.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
More people could be offered genetic testing for genes linked to ovarian cancer in new draft NICE guideline for public consultation19/09/2023 14:15:00
A new draft NICE guideline for inherited ovarian cancer published recently (15 September 2023), recommends more people are tested for genes linked to ovarian cancer.
More people could be offered genetic testing for genes linked to ovarian cancer in new draft NICE guideline for public consultation15/09/2023 15:25:00
A new draft NICE guideline for inherited ovarian cancer published today (15 September 2023), recommends more people are tested for genes linked to ovarian cancer
First treatment for acute migraine to be recommended by NICE set to benefit thousands14/09/2023 15:20:00
The first treatment to be recommended by NICE for treating acute migraine will soon be available on the NHS to around 13,000 people
NICE committee recommends tirzepatide as new treatment option for people with type 2 diabetes08/09/2023 16:10:00
Around 180,000 people with difficult to manage type 2 diabetes could benefit from a new treatment option recommended by NICE
More people could be treated out of hospital this winter through new draft NICE guidance to help identify and manage acute respiratory infections01/09/2023 16:25:00
Consultation launched on draft guidance for the assessment and management of acute respiratory infections in people over 16
Around 100,000 fewer colonoscopies expected to take place each year following updated NICE guidance25/08/2023 09:15:00
Tens of thousands of people a year could be spared the need for a colonoscopy following new guidance from NICE.
International heath technology assessment collaboration expands24/08/2023 15:15:00
The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada has welcomed two further HTA bodies.
NICE draft guidance recommends novel treatment for debilitating inherited skin condition18/08/2023 16:15:00
Around 670 people in England with painful and debilitating skin wounds caused by a rare inherited disorder are set to benefit from a new treatment to help the skin wounds heal faster
Technologies offering monitoring from home in virtual wards recommended for people with an acute respiratory infection18/08/2023 15:15:00
People with an acute respiratory infection (ARI) could be monitored from their own homes using technology platforms that will feedback vital information on their condition to clinical staff, NICE has said in draft guidance